New Path For 510(k)s On US FDA's FY 2018 Guidance-Priority Plan

FDA intends to draft a guidance by March outlining a voluntary, alternative 510(k) pathway for sponsors to demonstrate the substantial equivalence of some products by relying more on objective performance criteria.